LENZ Therapeutics (LENZ) EPS (Basic) (2020 - 2026)
LENZ Therapeutics (LENZ) posted quarterly EPS (Basic) of -$1.35 for Q1 2026, down 132.95% year-over-year from $4.09 in Q1 2025, and down 8.06% quarter-over-quarter from -$1.25 in Q4 2025.
LENZ Therapeutics (LENZ) EPS (Basic) (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has reported EPS (Basic) for 7 consecutive years, with -$1.35 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 132.95% year-over-year to -$1.35; the TTM figure through Mar 2026 stood at -$3.5 (down 96.47% YoY), while the FY2025 annual figure was -$2.85, down 21.88% from the prior year.
- EPS (Basic) retreated to -$1.35 in Q1 2026 per LENZ's latest filing, from -$1.25 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.38 in Q3 2024 and bottomed at -$81.63 in Q2 2022.
- Historically, EPS (Basic) has averaged -$7.02 across 5 years, with a median of -$2.18 in 2023.
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 94.22% — and 2026, when it slumped 132.95%.
- LENZ Therapeutics' EPS (Basic) stood at -$3.62 in 2022, then surged by 38.28% to -$2.23 in 2023, then soared by 73.36% to -$0.59 in 2024, then plunged by 109.55% to -$1.25 in 2025, then declined by 8.06% to -$1.35 in 2026.
- Business Quant data shows LENZ's EPS (Basic) at -$1.35 in Q1 2026, -$1.25 in Q4 2025, and -$0.59 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 0.18 |
| 10 | LENZ Therapeutics | 148.34 Mn | 148.34 Mn | 5.21 Mn | -1.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.02 |
| Mar 31, 2026 | -1.35 |
| Dec 31, 2025 | -1.25 |
| Sep 30, 2025 | -0.59 |
| Jun 30, 2025 | -0.53 |
| Mar 31, 2025 | -0.58 |
| Dec 31, 2024 | -0.59 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -3.42 |
| Dec 31, 2023 | -2.23 |
| Sep 30, 2023 | -6.51 |
| Jun 30, 2023 | -6.14 |
| Mar 31, 2023 | -2.18 |
| Dec 31, 2022 | -3.62 |
| Sep 30, 2022 | -4.34 |
| Jun 30, 2022 | -81.63 |
| Mar 31, 2022 | -3.58 |
| Dec 31, 2021 | -5.07 |
| Sep 30, 2021 | -7.29 |